5-ASA Dose-Response: Maximizing Efficacy and Adherence. - Wikidata - awgldk - TriplyDB

5-ASA Dose-Response: Maximizing Efficacy and Adherence.

5-ASA Dose-Response: Maximizing Efficacy and Adherence.

http://www.wikidata.org/entity/Q33916329

about

Addition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 Mice

P2860

Q28551369-4E9F139D-3B2C-4D45-8FB1-C8CBACC4492B

P2860

5-ASA Dose-Response: Maximizing Efficacy and Adherence.

http://www.wikidata.org/entity/Q33916329

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

5-ASA Dose-Response: Maximizing Efficacy and Adherence.

@ast

5-ASA Dose-Response: Maximizing Efficacy and Adherence.

@en

type

label

5-ASA Dose-Response: Maximizing Efficacy and Adherence.

@ast

5-ASA Dose-Response: Maximizing Efficacy and Adherence.

@en

prefLabel

5-ASA Dose-Response: Maximizing Efficacy and Adherence.

@ast

5-ASA Dose-Response: Maximizing Efficacy and Adherence.

@en

P1433

Q33916329-51A3F121-CF0D-402F-8940-F876DFFB3FB2

P1476

Q33916329-15E1B634-C6AB-4FA7-9505-5335988D49AC

P2093

Q33916329-8070084A-936D-4F26-8CA5-CFCB9FFC195C

Q33916329-94AD9598-DE8B-4BEB-B8E6-7CE9FC5122CA

P2860

Q33916329-1C7382E3-A67F-4512-9B65-7F2E7D6B3D56

Q33916329-1D70FEF9-168A-4D89-9D58-3A666C081ECA

Q33916329-2CFA6DC8-5766-48C8-AE8E-3A6280CD01F4

Q33916329-3FC355BD-5D8A-4E88-B7BF-73342D8F9EC3

Q33916329-4ABE38EE-E2EB-47B9-A221-A6CFDC128C77

Q33916329-501EA775-89A8-4414-B001-595444F856D9

Q33916329-5380F5F7-218D-4C3B-A486-0BDF9E76B474

Q33916329-5CA37A6C-4331-47B4-BE21-B6D266ECBBB8

Q33916329-651135D6-0E0B-406B-B6DB-229601F947FB

Q33916329-6A975AA8-83F9-47B9-95BE-7E203591C558

P304

Q33916329-D8663769-75EA-4FEB-A1F6-6CF9B178584F

P31

Q33916329-CDCACA7B-F87F-4C9D-A9CE-6537C9206975

P433

Q33916329-A90E4EB2-F359-404D-8DB8-BDF3E55214AA

P478

Q33916329-9EBC6279-14C1-4AA8-A121-C2A19767E583

P50

Q33916329-8F47481A-2C03-4579-B5A5-3D13E9FDC360

P577

Q33916329-57BF5AB7-1581-47A5-B1BA-F9425E266C01

P698

Q33916329-5CE0335E-E678-4999-A0B2-2164718D2827

P932

Q33916329-2A0EBD14-1E8F-40D2-BAC0-20697EB9C237

P1433

Gastroenterology & hepatology

P1476

5-ASA Dose-Response: Maximizing Efficacy and Adherence

@en

P2093

Gary R Lichtenstein

http://www.w3.org/2001/XMLSchema#string

Michael A Safdi

http://www.w3.org/2001/XMLSchema#string

P2860

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

Methotrexate for maintenance of remission in ulcerative colitis

Infliximab for induction and maintenance therapy for ulcerative colitis

A systematic review of the associations between dose regimens and medication compliance.

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.

Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.

Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial.

Therapeutic strategies for the management of ulcerative colitis.

Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.

P304

1-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

2 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20567558

http://www.w3.org/2001/XMLSchema#string

P932

2886460

http://www.w3.org/2001/XMLSchema#string